Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Greater Cannabis Company (GCAN) EBITDA Margin (2017 - 2021)

Greater Cannabis Company has reported EBITDA Margin over the past 5 years, most recently at 494.65% for Q2 2021.

  • For Q2 2021, EBITDA Margin fell 32417.0% year-over-year to 494.65%; the TTM value through Dec 2021 reached 2716.91%, down 215651.0%, while the annual FY2021 figure was 2716.91%, 210402.0% down from the prior year.
  • EBITDA Margin for Q2 2021 was 494.65% at Greater Cannabis Company, down from 170.47% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 99.52% in Q1 2018 and troughed at 43656.16% in Q2 2017.
  • A 5-year average of 11043.77% and a median of 494.65% in 2021 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: skyrocketed 4375550bps in 2018 and later crashed -32417bps in 2021.
  • Year by year, EBITDA Margin stood at 28856.62% in 2017, then soared by 100bps to 99.34% in 2018, then tumbled by -4456bps to 4327.33% in 2019, then soared by 96bps to 170.47% in 2020, then crashed by -190bps to 494.65% in 2021.
  • Business Quant data shows EBITDA Margin for GCAN at 494.65% in Q2 2021, 170.47% in Q2 2020, and 4327.33% in Q4 2019.